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Complement was originally discovered as a com-
ponent of normal plasma that augments opsonisa-
tion of bacteria by antibodies with subsequent
killing of the pathogen. Complement plays a cru-
cial role in innate and adaptive immune responses
to many blood-borne pathogens [1,2], and some
pathogens subvert complement function to survive
in the blood. Its role inA. phagocytophilum infection
has not been explored.
We previously showed reduced phagocytosis
by neutrophils infected by A. phagocytophilum.
Reduced phagocytosis and opsonophagocytic
receptor loss could allow A. phagocytophilum to
avoid killing by either the neutrophil or by
complement activation. Such changes could result
from down-regulated expression or shedding of
opsonophagocytic receptors on neutrophil sur-
faces, including various Fc receptors and comple-
ment receptors that bind opsonising ligands such
as IgG, IgA, IgE, or complement components. This
hypothesis was previously tested in our labora-
tory by assaying for the expression of these
receptors after 24 h of A. phagocytophilum infection
in human neutrophils. A. phagocytophilum-infected
neutrophils had signiﬁcantly reduced levels of
surface-exposed receptors C1qRp, FcRI, FcRII and
FcRIII 24 h after infection. The expression of CR1
was slightly reduced, and there was very low or
no expression of FcRII and FcRI in all cells [3].
The fact that A. phagocytophilum alters reactions
involving components of the complement system
raises a more important question: how does it
survive in the presence of complement factors
during bloodstream infection,where other bacteria
are usually effectively removed? Because other
bloodstream bacterial pathogens, such as Borrelia
burgdorferi [4] and Streptococcus pneumoniae [5],
have evolved towards mechanisms that preclude
complement-mediated opsonisation, assembly
and lysis, it suggests thatA. phagocytophilum is also
likely to have evolved towards such mechanisms.
We therefore hypothesised that A. phagocytophilum
evades complement-mediated degradation to
ensure survival.
A. phagocytophilum growth in human AB serum
(NHS) with known CH50 lytic activity was
compared with its growth in other serum supple-
ments. HL-60 cells were used directly or after
acclimation to 5% heat-inactivated (HI) NHS for
2–4 weeks. Experimental conditions included
infected HL-60 cells in fetal bovine serum (FBS),
HI-FBS, NHS and HI-NHS. Experiments were
performed at 2.0 · 105 cells ⁄mL starting at
concentrations with differing initial infection
rates. Infections were allowed to propagate for
5 days or until 100% infection was achieved, and
bacterial load was quantiﬁed by qPCR using the
DDCt method or by using a standard curve of
infected cells, and by light microscopy.
Without adaptation to NHS, A. phagocytophilum
grew equally well in HI-NHS as in NHS, but
neither condition supported growth as well as
FBS (not shown). Once adapted to NHS, A. phago-
cytophilum grew more rapidly (maximum infec-
tion by day 5 vs. day 6–8 for other sera) than with
HI-NHS, HI-FBS or FBS (Fig. 1), as quantitated by
the DDCt method and in a separate experiment by
the infected cell standard curve. Compared with
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HI-FBS, msp2 content at d5 was 71-fold greater for
NHS but only two-fold higher for HI-NHS and
FBS. Despite the increased genomic content in
NHS, morphologic quantitation of A. phagocyto-
philum infected HL-60 cells at day 5 revealed
fewer infected cells with an increased number of
morulae per infected cell in NHS (60%) and
HI-NHS (54%) compared with FBS (100%) and
HI-FBS (100%). Uninfected cell counts and actB
content were similar among all cultures, demon-
strating that HL-60 cells remained healthy and
viable under these different conditions.
Anaplasma phagocytophilum survives and prop-
agates better in human complement-containing
medium in vitro than in FBS. The lower number of
infected cells and the higher genomic content in
NHS cultures suggest a facilitated adhesion or
uptake mediated by complement. These observa-
tions underscore the pathogen’s ability to avoid a
heat-labile component, possibly complement-
mediated killing, and suggest that A. phagocyto-
philum subverts complement to facilitate infection.
Further study to determine whether complement
is degraded, if C3 convertases are formed, and
whether complement regulatory factors such as
Factor H are utilised, will help elucidate the
nature of A. phagocytophilum-complement cascade
interactions or if the pathogen inﬂuences comple-
ment regulatory mechanisms to avoid killing and
promote expansion and transmission.
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Fig. 1. Comparative growth of Anaplasma phagocytophilum
in heat inactivated and complement-containing FBS and
normal human serum (NHS). Note the rapid expansion of
bacterial load when incubated in NHS at 5 days compared
with heat-inactivated and other serum supplements.
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